These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26448142)

  • 21. Halofantrine in acute malaria.
    Sorabjee JS
    J Assoc Physicians India; 1994 May; 42(5):425. PubMed ID: 7718040
    [No Abstract]   [Full Text] [Related]  

  • 22. Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439).
    Kim HS; Hammill JT; Guy RK
    J Med Chem; 2017 Apr; 60(7):2651-2653. PubMed ID: 28296396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent dengue and malaria due to Plasmodium falciparum and P. vivax.
    Kaushik RM; Varma A; Kaushik R; Gaur KJ
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1048-50. PubMed ID: 17568646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimalarial drug combinations in vastly different settings.
    Morrow RH
    Lancet; 2007 Feb; 369(9560):444-5. PubMed ID: 17292746
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug alert: halofantrine.
    Wkly Epidemiol Rec; 1993 Sep; 68(37):269-70. PubMed ID: 8217579
    [No Abstract]   [Full Text] [Related]  

  • 26. [Splenic infarction during P. falciparum and P. vivax malaria].
    Hovette P; Lecoules S; Boete F; Imbert P; Touze JE; Laroche R
    Presse Med; 1994 Sep 3-10; 23(26):1226. PubMed ID: 7831224
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 29. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.
    Snounou G; White NJ
    Trends Parasitol; 2004 Jul; 20(7):333-9. PubMed ID: 15193565
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
    Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
    Fryauff DJ; Leksana B; Masbar S; Wiady I; Sismadi P; Susanti AI; Nagesha HS; Syafruddin ; Atmosoedjono S; Bangs MJ; Baird JK
    Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifying national malaria treatment policies in Peru.
    Ruebush TK; Neyra D; Cabezas C
    J Public Health Policy; 2004; 25(3-4):328-45. PubMed ID: 15683069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
    Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
    Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halofantrine in G-6 PD deficiency.
    Handa R; Wig N; Aggarwal P; Suresh V; Biswas A; Wali JP
    J Assoc Physicians India; 1997 Nov; 45(11):899. PubMed ID: 11229205
    [No Abstract]   [Full Text] [Related]  

  • 35. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mixed malaria infection: is Plasmodium vivax good for you?
    Whitehorn J; Coltart C; Manser D; Doherty T
    Trans R Soc Trop Med Hyg; 2010 Mar; 104(3):240-1. PubMed ID: 19740502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The characteristics of the clinical course of malaria in Ethiopia].
    Loban KM; Popova SP
    Med Parazitol (Mosk); 1996; (2):10-3. PubMed ID: 8926925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid diagnostic test-based management of malaria: an effectiveness study in Papua New Guinean infants with Plasmodium falciparum and Plasmodium vivax malaria.
    Senn N; Rarau P; Manong D; Salib M; Siba P; Robinson LJ; Reeder J; Rogerson S; Mueller I; Genton B
    Clin Infect Dis; 2012 Mar; 54(5):644-51. PubMed ID: 22198787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of malaria in Norway.
    Mørch K; Myrvang B
    Tidsskr Nor Laegeforen; 2012 Mar; 132(6):664-7. PubMed ID: 22456148
    [No Abstract]   [Full Text] [Related]  

  • 40. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.